The official launch of Plasmidsaurus RNA-Seq will take place at ASHG 2025 in Boston, where Plasmidsaurus will host ...
The company says the system can benefit pharmaceutical and biotech firms seeking rapid feedback on drug candidates or genome editing.
EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...
The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...
A pioneering method enables simultaneous RNA and metabolite analysis in the same cell, revealing the molecular choreography underlying the biosynthesis of medically relevant natural products.
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
Background SIRT6 acts as a tumour suppressor in multiple cancers by regulating glucose and lipid metabolism, but its role in ...
News-Medical.Net on MSN
Thiostrepton suppresses rhabdomyosarcoma progression by targeting the PI3K–AKT pathway
Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas.
News-Medical.Net on MSN
Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug
Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback